Peripheral Vascular Endothelial Dysfunction in Patients With Angina Pectoris and Normal Coronary Arteriograms  by Lekakis, John P et al.
ENDOTHELIAL FUNCTION
Peripheral Vascular Endothelial Dysfunction in Patients With Angina
Pectoris and Normal Coronary Arteriograms
JOHN P. LEKAKIS, MD, CHRISTOS M. PAPAMICHAEL, MD, COSTAS N. VEMMOS, MD,
ANASTASIOS A. VOUTSAS, MD, STAMATIOS F. STAMATELOPOULOS, MD,
SPYRIDON D. MOULOPOULOS, MD
Athens, Greece
Objectives. We sought to determine endothelium-dependent
vasodilator function in the brachial artery of patients with micro-
vascular angina pectoris.
Background. Previous studies suggest the presence of endothe-
lial dysfunction of the coronary microcirculation in patients with
microvascular angina pectoris. It is not known whether endothe-
lial dysfunction in these patients is a generalized process or
whether it is confined to the coronary microcirculation only.
Methods. In 11 women (mean [6SD] age 60.1 6 7.8 years) with
microvascular angina (anginal pain, normal epicardial coronary
arteries, positive exercise stress test), endothelium-dependent
vasodilation was assessed in the brachial artery by measuring the
change in brachial artery diameter in response to hyperemic flow.
Results were compared with 11 age- and gender-matched patients
with known three-vessel coronary artery disease and 11 age- and
gender-matched healthy control subjects. In all subjects, the
intima–media thickness (IMT) of the common carotid artery was
also measured.
Results. Flow-mediated dilation (FMD) was comparable in
patients with microvascular angina and coronary artery disease
(1.9 6 2.5% vs. 3.3 6 3.3%, p 5 NS) but was significantly lower in
patients with microvascular angina than in healthy control sub-
jects (1.9 6 2.5% vs. 7.9 6 3%, p < 0.05). IMT was significantly
lower in patients with microvascular angina than in those with
coronary artery disease (0.64 6 0.08 vs. 1.0 6 0.28 mm, p < 0.05)
and was comparable between patients with microvascular angina
pectoris and healthy control subjects (0.64 6 0.08 vs. 0.56 6
0.14 mm, p 5 NS). IMT >20.8 mm was observed in 1 of 11 patients
with microvascular angina, 1 of 11 control subjects and 10 of 11
patients with coronary artery disease.
Conclusions. These findings suggest that endothelial dysfunc-
tion in microvascular angina is a generalized process that also
involves the peripheral conduit arteries and is similar to that
observed in atherosclerotic disease. IMT could be helpful in
discriminating patients with microvascular angina and athero-
sclerotic coronary artery disease.
(J Am Coll Cardiol 1998;31:541–6)
©1998 by the American College of Cardiology
Inadequate vasodilation in response to metabolic or pharma-
cologic stimuli characterizes patients with angina pectoris and
normal results on coronary arteriography. Endothelium-
dependent coronary vasodilation is specifically impaired in these
patients in whom abnormal dilation of coronary microcircula-
tion may contribute to myocardial ischemia (1,2). Supplemen-
tation of L-arginine, a precursor of endothelium-derived nitric
oxide, improves defective endothelium-dependent vasodilation
in patients with microvascular angina (3), indicating that
endothelial dysfunction in these patients resulted from defec-
tive synthesis or release of nitric oxide, or both.
Endothelial dysfunction appears to be a generalized
process. A close correlation between coronary artery
endothelium-dependent vasomotor responses to acetylcholine
and brachial vasodilator response to reactive hyperemia has
been demonstrated in patients with coronary artery disease (4).
The value of abnormal brachial dilation in predicting abnormal
coronary endothelium is high in these patients. In patients with
microvascular angina, an impaired forearm vasodilator re-
sponse to ischemia has been observed (5), suggesting that the
vascular involvement is not restricted to the coronary circula-
tion but is part of a generalized vasomotor disturbance.
Intima–media thickness (IMT) of the common carotid
artery has been suggested as a surrogate marker for coronary
atherosclerosis. An association of coronary atherosclerosis
status with IMT has been previously described (6). It is not
known whether carotid IMT is also abnormal in patients with
microvascular angina.
Thus, the present study sought to 1) determine whether
endothelial dysfunction is present in peripheral conduit arter-
ies of patients with microvascular angina, and 2) examine IMT
in these patients.
Methods
Study patients. Eleven female patients with microvascular
angina were included in the study (mean [6SD] age 60.1 6 7.8
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years, range 49 to 72). Diagnostic criteria for microvascular
angina were typical angina pectoris during exercise or at rest,
positive exercise stress test results, with ST segment depression
$0.2 mV and normal epicardial coronary arteries. In eight
patients, an exercise thallium-201 test was performed and
showed reversible myocardial perfusion defects. No patient
had a previous myocardial infarction or valvular heart disease.
The control subjects were 11 healthy volunteers without angi-
nal chest pain and normal results on the exercise stress test,
matched for age and gender with the 11 patients with micro-
vascular angina. A second control group included 11 patients
with known coronary artery disease with no history of myocar-
dial infarction and three-vessel disease on coronary angiogra-
phy, matched for age and gender with the patients with
microvascular angina. No patient or control subject had dia-
betes mellitus, and none were taking estrogen replacement
therapy. All medications were withdrawn $48 h before the
study. All patients and control subjects gave informed consent
before entering the study. The clinical characteristics of the
patients and control subjects are shown in Table 1.
Study protocol. Brachial artery endothelial function study.
Each subject was studied in the morning, after abstaining from
alcohol, caffeine and tobacco as well as food within 8 h before
the study. High resolution echocardiography–Doppler ultra-
sound (Acuson 128XP) with a 7.0-MHz transducer was used to
measure the flow velocity and diameter of the right brachial
arteries. In all studies, scans were taken at rest, during reactive
hyperemia (endothelium-dependent stimulus to vasodilation),
again at rest and after sublingual nitroglycerin (endothelium-
independent vasodilation). The intraobserver and interob-
server variabilities for repeated measurements are 0.1 6 0.12
and 0.08 6 0.19 mm, respectively, in our laboratory. When
reactive hyperemia studies were performed on 2 separate days,
the mean difference in brachial vasodilator response in abso-
lute terms was 1.1 6 1%.
Each subject rested quietly for 10 min before the scan.
When a satisfactory position was found, the skin was marked,
a scan was recorded at rest, and arterial flow velocity was
measured using a pulsed Doppler signal at 60° angle in the
center of the artery. Blood flow through the brachial artery was
altered with an occluding cuff placed in the forearm ;8 cm
distal to the site of brachial artery measurement (7). By
inflating the cuff to 250 to 300 mm Hg, distal circulation arrest
was obtained, and flow was reduced through the brachial artery
measured proximal to the cuff. By deflating the cuff after 5 min
of inflation, flow through the brachial artery was increased
(reactive hyperemia). The brachial artery was scanned contin-
uously 30 s before and 90 s after cuff deflation. Ten minutes
later, a second rest scan was recorded. Nitroglycerin (400 mg)
was then administered sublingually, and the artery was scanned
5 min later.
All images were recorded on super-VHS videotape and
later analyzed by two observers (J.L., C.P.) who did not know
the identity of the subject or the scan sequence. Artery
diameter measurements were made at end-diastole (peak of R
wave on the electrocardiogram) using electronic calipers. Five
cardiac cycles were analyzed, and measurements were aver-
aged. Brachial artery diameter measurements after reactive
Abbreviations and Acronyms
FMD 5 flow-mediated dilation
IMT 5 intima–media thickness
NID 5 nitrate-induced dilation




(yr)/Gender Chol TG Smoking HTN
MVA
1 57/F 212 135 1 2
2 72/F 190 98 2 1
3 64/F 225 142 2 2
4 68/F 200 116 2 2
5 64/F 234 162 2 1
6 52/F 188 92 2 2
7 55/F 218 122 2 2
8 62/F 245 158 2 2
9 51/F 198 141 2 1
10 49/F 225 92 2 2
11 68/F 232 115 1 2
Mean 60.18 215 124
SD 67.80 619 624
Normal
1 56/F 185 143 2 2
2 74/F 230 85 2 2
3 62/F 198 115 2 1
4 70/F 232 161 1 2
5 64/F 192 95 2 2
6 51/F 217 105 1 2
7 55/F 238 168 2 2
8 62/F 218 96 1 2
9 50/F 222 107 1 2
10 50/F 186 110 2 1
11 68/F 197 168 2 2
Mean 60.18 210 123
SD 68.40 619 631
CAD
1 57/F 227 168 2 1
2 71/F 218 105 2 1
3 63/F 236 175 2 2
4 69/F 196 117 1 2
5 64/F 187 132 2 1
6 53/F 227 145 1 1
7 56/F 238 89 2 2
8 61/F 245 115 2 1
9 51/F 234 127 1 1
10 50/F 204 96 2 2
11 68/F 215 178 1 1
Mean 60.27 220 131
6SD 67.39 618 631
CAD 5 patients with three-vessel coronary artery disease; Chol 5 choles-
terol; F 5 female; HTN 5 hypertension; M 5 male; MVA 5 patients with
microvascular angina; Normal 5 normal subjects; Pt 5 patient; Subj 5 subject;
TG 5 triglycerides; 1 5 yes; 2 5 no.
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hyperemia were taken 60 s after cuff deflation. Flow-mediated
dilation (FMD) was calculated as the percent increase in
arterial diameter during hyperemia versus the corresponding
rest value. Brachial artery diameter measurements after nitro-
glycerin were taken 5 min after nitroglycerin administration.
Nitrate-induced dilation (NID) was calculated as the percent
increase in arterial diameter after nitroglycerin versus the
corresponding rest value.
IMT measurement. B-mode ultrasound imaging was per-
formed using the same ultrasound machine (128XP Acuson,
7.0-MHz linear array transducer). The scanning method used
was similar to that proposed by Salonen and Salonen (8) and
Blankenhorn et al. (9). The common carotid arteries were
studied in longitudinal planes with anterior, lateral and poste-
rior approaches. The image was focused on the posterior wall,
and images of the distal 10 mm of the common carotid artery
were recorded from the approach showing the greatest dis-
tance between the lumen–intima interface and media–
adventitia interface. All scans were recorded on super-VHS
videotapes for subsequent analysis. Mean IMT was calculated
as the average of 10 measurements made manually in each
carotid by means of electronic calipers. Measurements were
made by consensus of two observers (J.L., C.P.) unaware of the
identity of the subject.
Statistical evaluation. Results are expressed as mean
value 6 SD. Differences between cholesterol, triglycerides,
brachial artery vasodilator responses and IMT were evaluated
and analyzed by one-way analysis of variance. If this test was
positive, the Student-Newman-Keuls test was performed to
evaluate differences among the three groups. A p value ,0.05
was considered statistically significant.
Results
Patients. Table 1 shows the clinical characteristics of pa-
tients and control subjects. All participants were women, and
age was well matched among the three groups. There were no
significant differences in cholesterol and triglyceride levels and
smoking habits and arterial hypertension were comparable in
all groups.
Brachial artery diameter. Baseline brachial artery diame-
ter was comparable in patients with microvascular angina
(3.7 6 0.5 mm), patients with coronary artery disease (3.5 6
0.6 mm) and healthy control subjects (3.5 6 0.6 mm). The
time-averaged flow velocity during peak reactive hyperemia, a
measure of the stimulus for dilation was similar in all three
groups (71 6 19 cm/s in patients with microvascular angina,
73 6 23 cm/s in patients with coronary artery disease, 76 6
10 cm/s in healthy control subjects) (Table 2).
FMD. FMD was 1.9 6 2.5% in patients with microvascular
angina (range 23% to 6%), significantly lower than that in
healthy volunteers (7.9 6 3%, range 3% to 12%, p , 0.05) and
comparable to that observed in patients with three-vessel
coronary artery disease (3.3 6 3.3%, range 0% to 10%, p 5
NS) (Fig. 1). In a subset of six patients with microvascular
angina without risk factors for atherosclerosis, FMD was 1.5 6
2.7%, significantly lower than that in a subset of five normal
healthy volunteers without risk factors (FMD 7.2 6 2.7%, p ,
0.01).
Nitrate-induced dilation. Nitrate-induced dilation (NID)
was 22 6 13% in patients with microvascular angina (range 6%
to 40%) and did not differ significantly from that in healthy
control subjects (24 6 7%, range 12% to 39%, p 5 NS) or
patients with three-vessel coronary artery disease (18 6 7%,
range 3% to 33%, p 5 NS) (Fig. 2).
IMT. IMT was 0.64 6 0.08 mm in patients with microvas-
cular angina (range 0.5 to 0.7), significantly lower than that in
patients with three-vessel coronary artery disease (1.0 6
0.28 mm, range 0.6 to 1.6, p , 0.05) and comparable to values
observed in healthy volunteers (0.56 6 0.14 mm, range 0.4 to
0.8, p 5 NS).
IMT $0.8 mm was observed in 1 of 11 patients with
microvascular angina, 1 of 11 healthy volunteers and 10 of 11
patients with three-vessel coronary artery disease (Fig. 3).
Discussion
In the present study we examined vascular endothelial and
smooth muscle function in the large vessels of patients with
microvascular angina by means of a simple noninvasive
method that is known to enable accurate and reproducible
assessment of the vascular responses to flow increase and
nitrates (7,10). In animals, flow-dependent dilation is endothe-
lium dependent and is mediated by nitric oxide (11,12). The
Table 2. Vessel Size and Time-Averaged Velocity at Reactive








MVA 3.7 6 0.5 71 6 19
Normal 3.5 6 0.6 76 6 10
CAD 3.5 6 0.6 73 6 23
Data presented are mean value 6 SD. Abbreviations as in Table 1.
Figure 1. FMD in patients with microvascular angina (MVA), control
subjects and patients with coronary artery disease (CAD). Ovals 5
mean value; vertical lines 5 standard deviation.
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same mechanism is essential for FMD of large human arteries
(13). Hence, this test can be used as an estimate of the capacity
of human endothelial cells to release nitric oxide in response to
a physiologic stimulus as well as an estimate of endothelial
dysfunction in diseased states. To distinguish endothelial from
intrinsic smooth muscle dysfunction, we used nitroglycerin, an
endothelium-independent vasodilator. Nitrates cause smooth
muscle relaxation, acting directly by increasing cyclic
guanosine monophosphate levels of smooth muscle cells.
Endothelial function in patients with microvascular an-
gina. The results of the present study in the brachial artery
clearly indicate the presence of endothelial dysfunction in
patients with microvascular angina comparable to that ob-
served in patients with extended atherosclerotic heart disease.
It has been previously shown (1,2) that acetylcholine-induced
vasodilation of coronary microcirculation is impaired in micro-
vascular angina. Microvascular endothelial dysfunction may
contribute to the reduced vasodilator reserve during atrial
pacing and anginal chest pain in these patients. Some degree of
abnormal response of epicardial coronary arteries to acetyl-
choline was also present in the majority (71%) of the patients
with microvascular angina (2). Intracoronary infusion of
L-arginine (3) markedly improved endothelium-dependent va-
sodilation of the coronary microcirculation in these patients,
suggesting that impaired acetylcholine-induced endothelium-
dependent vasodilation of the coronary microcirculation in
patients with microvascular angina resulted from defective
synthesis or release of nitric oxide, or both.
Further evidence is provided by the present data that
endothelial dysfunction in patients with microvascular angina
is not confined to the coronary microcirculation but also
extends to large peripheral conduit arteries. It has been
previously proposed (5,14,15) that some patients with limited
microvascular vasodilator capacity may present a more gener-
alized disorder, leading to an attenuated hyperemic response
to transient forearm ischemia, esophageal motility abnormali-
ties or bronchoconstrictor responses to metacholine inhala-
tion. Morphologic changes of subcutaneous small arteries have
been described (16) in patients with microvascular angina,
although no significant functional abnormalities were associ-
ated with the observed structural changes in vitro. These
results suggest that there is a generalized abnormality in the
vascular tree in microvascular angina rather than one confined
to the heart. It is also known that endothelial dysfunction is a
generalized process, not necessarily confined to vascular beds
with clinically overt atherosclerosis. The brachial vasodilator
response to reactive hyperemia was closely related to the
coronary vasodilator response to acetylcholine (4) and to the
extent of coronary atherosclerosis (17) in patients with athero-
sclerotic heart disease. Botker et al. (18) using the same
technique were unable to detect differences in flow-mediated
vasodilation between patients with microvascular angina and
control subjects. They reported a percent diameter change of
the brachial artery in response to reactive hyperemia in these
patients of 2.7%, a value similar to that observed in our study
(1.9%). Although their control subjects also showed an abnor-
mal response to hyperemic flow (FMD 4.2%) that was signif-
icantly lower than the normal values observed in our study as
well as in previous studies (7,19); the apparently abnormal
Figure 2. NID in patients with microvascular angina (MVA), control
subjects and patients with coronary artery disease (CAD). Symbols as
in Figure 1.
Figure 3. IMT in patients with microvascular angina (MVA), control
subjects and patients with coronary artery disease (CAD). Symbols as
in Figure 1.
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response of the control group might preclude a significant
difference in FMD between patients with microvascular angina
and control subjects in that study (18).
The response to nitroglycerin was normal in our patients
with microvascular angina, suggesting a selective endothelial
dysfunction rather than a disorder of smooth muscle cell
responsiveness. Quyyumi et al. (2) also showed that microvas-
cular coronary dilation caused by sodium nitroprusside was not
abnormal in patients with microvascular angina, indicating that
the vasodilator defect in the coronary microcirculation was not
caused by smooth muscle dysfunction.
It is noticeable that in our study, patients with microvascu-
lar angina presented with the same degree of endothelial
dysfunction in peripheral arteries as patients with extended
coronary artery disease. It has been reported (4,7) that the
brachial dilator response to reactive hyperemia is blunted in
patients with coronary artery disease compared with that in
control subjects without coronary disease; the response to
nitroglycerin appears to be normal in these patients.
B-mode ultrasound of the carotid circulation has been
proposed as a useful measure for clinical screening of patients
with chest pain syndromes and for use in clinical trials. Autopsy
studies have shown that the extent of extracranial carotid and
coronary atherosclerosis is well correlated (20,21). Common
carotid IMT is correlated with traditional vascular risk factors
(22); is higher in the presence of aortic, femoral or carotid
plaque (21); may predict the likelihood of acute coronary
events (8); and is significantly although weakly correlated with
the extent and severity of coronary artery disease (23). In 1990
Craven et al. (24) compared subjects with severe coronary
artery disease (one or more vessels with $50% stenosis) with
subjects having no coronary disease and found that IMT was
greater in patients. In our study, the two groups with and
without coronary atherosclerosis could be discriminated on the
basis of carotid IMT. A thickness .0.8 mm was helpful in
discriminating these two groups with a similar degree of
endothelial dysfunction in the conduit arteries.
Limitations of the study. Some of our patients and control
subjects had coronary risk factors that may influence endothe-
lial function and IMT (22,25,26). However, it is unlikely that
the presence of risk factors influenced the present results
because the incidence of factors such as smoking and hyper-
tension was similar in the three groups, whereas the levels of
cholesterol and triglycerides were comparable. Furthermore,
in a subset of patients with microvascular angina without risk
factors for atherosclerosis, FMD was lower than that in a
subset of healthy control subjects without risk factors. A
second limitation is that all patients were women, and thus
conclusions may not extend to the male population; neverthe-
less, there is a female prevalence among patients with micro-
vascular angina (27,28). Finally, these findings do not apply to
women who are premenopausal; however, the majority of
patients with microvascular angina are postmenopausal
women (28,29).
Conclusions. The present study demonstrated that in pa-
tients with microvascular angina, endothelial dysfunction is a
generalized process involving the peripheral conduit arteries
and is similar to that observed in atherosclerotic heart disease.
Common carotid IMT measurement might be a useful method
for discriminating patients with microvascular angina and
atherosclerotic coronary artery disease.
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